What is IROA Technologies?
Founded in 2010, IROA Technologies is dedicated to advancing metabolomics research through innovative products and services. Their offerings include stable isotope-labeled biochemical standards, comprehensive libraries for mass spectrometry, and sophisticated data analytics software. By providing an automated metabolomics workflow, IROA Technologies enhances the accuracy and reproducibility of mass spectrometry-based measurements, ensuring reliable results across diverse experimental batches and laboratory settings. The company primarily serves clients engaged in clinical metabolomics, aiming to accelerate the identification of critical biomarkers and the characterization of phenotypes.
How much funding has IROA Technologies raised?
IROA Technologies has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
What's next for IROA Technologies?
With the recent influx of substantial expansion capital, IROA Technologies is poised for significant scaling and market penetration. This strategic investment is expected to fuel further development of their innovative metabolomics solutions, potentially expanding their product lines and enhancing their data analytics capabilities. The company's trajectory suggests a strong focus on solidifying its position in the clinical metabolomics sector, driving advancements in biomarker discovery and phenotype characterization, and potentially exploring new applications for their technology.
See full IROA Technologies company page
